Abstract
The characteristics of ncRNA in children with autism spectrum disorder (ASD) were observed to disclose a theoretical basis for further research on molecular markers for early warning of ASD. Children with ASD and normal control children were recruited to collect peripheral blood RNA samples. The concentration of PVT1 and miR-21-5p was quantitatively analyzed by qRT-PCR. Pearson correlation coefficient method was used to evaluate the link between PVT1 level and miR-21-5p level of the children. Receiver operating characteristic (ROC) curves were applied to reckon the predictive value of PVT1, miR-21-5p, and their combination in ASD. The interconnection of PVT1 with miR-21-5p was represented by luciferase reporter assay. The targeted genes of miR-21-5p were predicted. The enrichment and protein interaction analysis of these genes was carried out to find the important core genes and analyze their value in ASD. In the disease group, the level of PVT1 was downregulated, while the content of miR-21-5p was upregulated. The expression level of serum miR-21-5p was negatively correlated with the level of PVT1. Luciferase reporter gene assay documented that PVT1 directly targeted miR-21-5p. ROC curve showed that PVT1, miR-21-5p, and their combination showed clinical value for disease diagnosis. The functional enrichment analysis showed that the targets of miR-21-5p participated in ASD by regulating related functions and pathways. Reduced expression of PVT1 and raised miR-21-5p were good diagnostic markers for ASD, which would provide a basis for effective prevention, early diagnosis, and early intervention of ASD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Alvarez-Arellano L, Salazar-García M, Corona JC (2020) Neuroprotective effects of quercetin in pediatric neurological diseases. Molecules (Basel, Switzerland) 25. https://doi.org/10.3390/molecules25235597
Aspra Q et al (2022) Epigenome-wide analysis reveals DNA methylation alteration in ZFP57 and its target RASGFR2 in a Mexican population cohort with autism. Children (Basel, Switzerland) 9. https://doi.org/10.3390/children9040462
Chen J, Ren H, Liu B (2022a) Evaluating the potency of blood long noncoding RNA PVT1 as candidate biomarker reflecting inflammation, multiple organ dysfunction, and mortality risk in sepsis patients. J Clin Lab Anal 36:e24268. https://doi.org/10.1002/jcla.24268
Chen L, Gong HY, Xu L (2018) PVT1 protects diabetic peripheral neuropathy via PI3K/AKT pathway. Eur Rev Med Pharmacol Sci 22:6905–6911. https://doi.org/10.26355/eurrev_201810_16160
Chen X, Peng Y, Xue H, Liu G, Wang N, Shao Z (2022b) MiR-21 regulating PVT1/PTEN/IL-17 axis towards the treatment of infectious diabetic wound healing by modified GO-derived biomaterial in mouse models. J Nanobiotechnol 20:309. https://doi.org/10.1186/s12951-022-01516-4
Conroy JN, Coulson EJ (2022) High-affinity TrkA and p75 neurotrophin receptor complexes: a twisted affair. J Biol Chem 298:101568. https://doi.org/10.1016/j.jbc.2022.101568
Cui D, Yu CH, Liu M, Xia QQ, Zhang YF, Jiang WL (2016) Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 37:4127–4134. https://doi.org/10.1007/s13277-015-4261-x
Di Paolo A et al (2020) PDCD4 regulates axonal growth by translational repression of neurite growth-related genes and is modulated during nerve injury responses. RNA (New York, NY) 26:1637–1653. https://doi.org/10.1261/rna.075424.120
Fallah H, Sayad A, Ranjbaran F, Talebian F, Ghafouri-Fard S, Taheri M (2020) IFNG/IFNG-AS1 expression level balance: implications for autism spectrum disorder. Metab Brain Dis 35:327–333. https://doi.org/10.1007/s11011-019-00510-4
Ghafouri-Fard S, Noroozi R, Brand S, Hussen BM, Eghtedarian R, Taheri M, Ebrahimzadeh K (2022) Emerging role of non-coding RNAs in autism spectrum disorder. J Mol Neurosci 72:201–216. https://doi.org/10.1007/s12031-021-01934-3
Gill PS et al (2022) Integrated microRNA-mRNA expression profiling identifies novel targets and networks associated with autism. J Pers Med 12. https://doi.org/10.3390/jpm12060920
Guo C et al (2022) Aberrant expressions of MIAT and PVT1 in serum exosomes of schizophrenia patients. Schizophrenia Res 240:71–72. https://doi.org/10.1016/j.schres.2021.12.013
Hu T, Dong Y, He C, Zhao M, He Q (2020) The gut microbiota and oxidative stress in autism spectrum disorders (ASD). Oxid Med Cell Longev 2020:8396708. https://doi.org/10.1155/2020/8396708
Iles A (2021) Autism spectrum disorders. Prim Care 48:461–473. https://doi.org/10.1016/j.pop.2021.04.003
Ilijoski B, Ackovska N, Zorcec T, Popeska Z (2022) Extending robot therapy for children with autism using mobile and web application. Sensors (Basel, Switzerland) 22. https://doi.org/10.3390/s22165965
India State-Level Disease Burden Initiative Mental Disorders Collaborators (2020) The burden of mental disorders across the states of India: The global burden of disease study 1990–2017. Lancet Psychiatry 7:148–161. https://doi.org/10.1016/s2215-0366(19)30475-4
Kodak T, Bergmann S (2020) Autism spectrum disorder: characteristics, associated behaviors, and early intervention. Pediatr Clin North Am 67:525–535. https://doi.org/10.1016/j.pcl.2020.02.007
Landa RJ (2018) Efficacy of early interventions for infants and young children with, and at risk for, autism spectrum disorders. Int Rev Psychiatry (Abingdon, England) 30:25–39. https://doi.org/10.1080/09540261.2018.1432574
Li A, Liao W, Xie J, Song L, Zhang X (2022) Plasma proteins as occupational hazard risk monitors for populations working in harsh environments: a mendelian randomization study. Front Public Health 10:852572. https://doi.org/10.3389/fpubh.2022.852572
Li M, Chi C, Zhou L, Chen Y, Tang X (2021) Circular PVT1 regulates cell proliferation and invasion via miR-149–5p/FOXM1 axis in ovarian cancer. J Cancer 12:611–621. https://doi.org/10.7150/jca.52234
Liang S et al (2019) Genome-wide DNA methylation analysis reveals epigenetic pattern of SH2B1 in Chinese monozygotic twins discordant for autism spectrum disorder. Front Neurosci 13:712. https://doi.org/10.3389/fnins.2019.00712
Liu J, Hu J, Li Q, Zhao X, Liu Y, Liu S (2022a) Atypical processing pattern of gaze cues in dynamic situations in autism spectrum disorders. Sci Rep 12:4120. https://doi.org/10.1038/s41598-022-08080-9
Liu S et al (2017) Diagnostic value of blood-derived micrornas for schizophrenia: Results of a meta-analysis and validation. Sci Rep 7:15328. https://doi.org/10.1038/s41598-017-15751-5
Liu YP et al (2022b) Exosome-mediated miR-21 was involved in the promotion of structural and functional recovery effect produced by electroacupuncture in sciatic nerve injury. Oxid Med Cell Longev 2022:7530102. https://doi.org/10.1155/2022/7530102
Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J (2018) Autism spectrum disorder. Lancet (London, England) 392:508–520. https://doi.org/10.1016/s0140-6736(18)31129-2
Lv ZH, Wang ZY, Li ZY (2019) LncRNA PVT1 aggravates the progression of glioma via downregulating UPF1. Eur Rev Med Pharmacol Sci 23:8956–8963. https://doi.org/10.26355/eurrev_201910_19294
Mahmoudi R, Saidijam M, Nikzad S, Tapak L, Alvandi M, Afshar S (2022) Human exposure to low dose ionizing radiation affects miR-21 and miR-625 expression levels. Mol Biol Rep 49:1321–1327. https://doi.org/10.1007/s11033-021-06960-3
Mansur F et al (2021) Complement C4 is reduced in iPSC-derived astrocytes of autism spectrum disorder subjects. Int J Mol Sci 22. https://doi.org/10.3390/ijms22147579
Mor M, Nardone S, Sams DS, Elliott E (2015) Hypomethylation of miR-142 promoter and upregulation of microRNAs that target the oxytocin receptor gene in the autism prefrontal cortex. Mol Autism 6:46. https://doi.org/10.1186/s13229-015-0040-1
Pan B et al (2023) Long noncoding RNA Pvt1 promotes the proliferation and migration of Schwann cells by sponging microRNA-214 and targeting c-Jun following peripheral nerve injury. Neural Regen Res 18:1147–1153. https://doi.org/10.4103/1673-5374.353497
Richards R, Greimel E, Kliemann D, Koerte IK, Schulte-Körne G, Reuter M, Wachinger C (2020) Increased hippocampal shape asymmetry and volumetric ventricular asymmetry in autism spectrum disorder. NeuroImage Clin 26:102207. https://doi.org/10.1016/j.nicl.2020.102207
Safari MR, Komaki A, Arsang-Jang S, Taheri M, Ghafouri-Fard S (2019) Expression pattern of long non-coding rnas in schizophrenic patients. Cell Mol Neurobiol 39:211–221. https://doi.org/10.1007/s10571-018-0640-3
Shulman C, Esler A, Morrier MJ, Rice CE (2020) Diagnosis of autism spectrum disorder across the lifespan child and adolescent. Psychiatr Clin North Am 29:253–273. https://doi.org/10.1016/j.chc.2020.01.001
Singh A et al (2021) The role of microRNA-21 in the onset and progression of cancer. Future Med Chem 13:1885–1906. https://doi.org/10.4155/fmc-2021-0096
Smith AM, King JJ, West PR, Ludwig MA, Donley ELR, Burrier RE, Amaral DG (2019) Amino acid dysregulation metabotypes: potential biomarkers for diagnosis and individualized treatment for subtypes of autism spectrum disorder. Biol Psychiatry 85:345–354. https://doi.org/10.1016/j.biopsych.2018.08.016
Taheri M, Honarmand Tamizkar K, Omrani S, Arsang-Jang S, Ghafouri-Fard S, Omrani MD (2021) MEG3 lncRNA is over-expressed in autism spectrum disorder. Metab Brain Dis 36:2235–2242. https://doi.org/10.1007/s11011-021-00764-x
Tamizkar KH, Ghafouri-Fard S, Omrani MD, Pouresmaeili F, Arsang-Jang S, Taheri M (2021) Altered expression of lncRNAs in autism spectrum disorder. Metab Brain Dis 36:983–990. https://doi.org/10.1007/s11011-021-00681-z
Tang Q, Zhang Y, Yue L, Ren H, Pan C (2022a) Ssc-MiR-21–5p and Ssc-MiR-615 regulates the proliferation and apoptosis of leydig cells by targeting SOX5. Cells 11. https://doi.org/10.3390/cells11142253
Tang SS, Li H, Tang CK (2022b) PVT1 in cardiovascular disease: a promising therapeutic target. Int J Cardiol 366:10. https://doi.org/10.1016/j.ijcard.2022.07.006
Tran SS et al (2019) Widespread RNA editing dysregulation in brains from autistic individuals. Nat Neurosci 22:25–36. https://doi.org/10.1038/s41593-018-0287-x
Vithayathil J, Pucilowska J, Landreth GE (2018) ERK/MAPK signaling and autism spectrum disorders. Prog Brain Res 241:63–112. https://doi.org/10.1016/bs.pbr.2018.09.008
Wakefield JC (2016) Diagnostic issues and controversies in DSM-5: return of the false positives problem. Ann Rev Clin Psychol 12:105–132. https://doi.org/10.1146/annurev-clinpsy-032814-112800
Wu F et al (2021) ZFP36L2 regulates myocardial ischemia/reperfusion injury and attenuates mitochondrial fusion and fission by LncRNA PVT1. Cell Death Dis 12:614. https://doi.org/10.1038/s41419-021-03876-5
Yuan F et al (2020) Overexpression of Smad7 in hypothalamic POMC neurons disrupts glucose balance by attenuating central insulin signaling. Mol Metab 42:101084. https://doi.org/10.1016/j.molmet.2020.101084
Zhang K, Liao P, Wen J, Hu Z (2023) Synaptic plasticity in schizophrenia pathophysiology. IBRO Neurosci Rep 14:244–252. https://doi.org/10.1016/j.ibneur.2023.01.008
Zhang L et al (2020) Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios. Transl Psychiatry 10:9. https://doi.org/10.1038/s41398-020-0692-2
Ziats MN, Rennert OM (2013) Aberrant expression of long noncoding RNAs in autistic brain. J Mol Neurosci: MN 49:589–593. https://doi.org/10.1007/s12031-012-9880-8
Author information
Authors and Affiliations
Contributions
All the authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Mingjun Jiang and Guanwen Chen. The first draft of the manuscript was written by Mingjun Jiang, and all the authors commented on the previous versions of the manuscript. All the authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethical Approval
This study was performed in line with the principles of the Declaration of Helsinki. The Ethics Committee of Shenzhen Polytechnic University provided the approval for this research.
Consent to Participate
The guardian of the study knew and signed the informed consent form before joining the study.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jiang, M., Chen, G. Investigation of LncRNA PVT1 and MiR-21-5p Expression as Promising Novel Biomarkers for Autism Spectrum Disorder. J Mol Neurosci 73, 865–873 (2023). https://doi.org/10.1007/s12031-023-02161-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-023-02161-8